Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 26,545 | 19,958 | 22,936 | 22,793 | 15,784 |
| Depreciation Amortization | 4,999 | 4,964 | 4,817 | 4,715 | 3,549 |
| Income taxes - deferred | 5,752 | 2,006 | 5,589 | 987 | -10,968 |
| Accounts receivable | -30,017 | -6,038 | 24,514 | -40,801 | 16,107 |
| Accounts payable and accrued liabilities | -1,547 | -457 | -12 | 7,105 | 5,463 |
| Other Working Capital | -25,185 | -21,374 | 25,543 | -32,517 | 33,870 |
| Other Operating Activity | 49,323 | 8,258 | -27,940 | 33,657 | -21,555 |
| Operating Cash Flow | $29,870 | $7,317 | $55,447 | $-4,061 | $42,250 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33,287 | -20,813 | -43,969 | -41,228 | -6,532 |
| Net Acquisitions | N/A | N/A | N/A | -218 | -559 |
| Other Investing Activity | 0 | -10,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-33,287 | $-30,813 | $-43,969 | $-41,446 | $-7,091 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 123 |
| Debt Issued | 57,183 | 60,000 | 33,195 | 32,430 | 31 |
| Debt Repayment | -48,648 | -60,751 | -18,015 | -1,569 | -1,110 |
| Common Stock Issued | 4,464 | 3,391 | 2,471 | 54,819 | 33 |
| Common Stock Repurchased | N/A | N/A | N/A | -192 | -337 |
| Dividend Paid | N/A | N/A | N/A | N/A | -5,400 |
| Other Financing Activity | 1,845 | 6,328 | 840 | 340 | 1,250 |
| Financing Cash Flow | $14,844 | $8,968 | $18,491 | $85,828 | $-5,410 |
| Exchange Rate Effect | 24 | 271 | -657 | -197 | -276 |
| Beginning Cash Position | 91,473 | 105,730 | 76,418 | 36,294 | 6,821 |
| End Cash Position | 102,924 | 91,473 | 105,730 | 76,418 | 36,294 |
| Net Cash Flow | $11,451 | $-14,257 | $29,312 | $40,124 | $29,473 |
| Free Cash Flow | |||||
| Operating Cash Flow | 29,870 | 7,317 | 55,447 | -4,061 | 42,250 |
| Capital Expenditure | -33,287 | -20,813 | -43,969 | -41,228 | -6,532 |
| Free Cash Flow | -3,417 | -13,496 | 11,478 | -45,289 | 35,718 |